Pharmacotherapy of ascariasis

Expert Opinion on Pharmacotherapy

Volumn 2, Issue 2, 2001, Pages 223-239

  St Georgiev, V ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Albendazole; Ascariasis; Ascaris lumbricoides; Ascaris suum; Ivermectin; Mebendazole; Pyogenic cholangitis; Pyrantel pamoate

Indexed keywords

AGRICULTURAL CHEMICAL; ALBENDAZOLE; AN HUI TONG; ANTHELMINTIC AGENT; ASCARIDOLE; BRONCHODILATING AGENT; CAMBENDAZOLE; CHENOPODIUM AMBROSIOIDES EXTRACT; CHLORPROMAZINE; CODEINE; CORTICOSTEROID; DIATRIZOATE; DIETHYLCARBAMAZINE; FICUS GLABRATA EXTRACT; GLUCAN; HERBACEOUS AGENT; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; IVERMECTIN; LATEX; LEVAMISOLE; MEBENDAZOLE; OXANTEL EMBONATE; OXIBENDAZOLE; PIPERAZINE CITRATE; PLACEBO; PRAZIQUANTEL; PYRANTEL EMBONATE; TIABENDAZOLE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ACUPUNCTURE; ADULT; ALOPECIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ASCARIASIS; ASCARIS LUMBRICOIDES; ASCARIS SUUM; BILE DUCT OBSTRUCTION; BONE MARROW SUPPRESSION; CAUSE OF DEATH; CHENOPODIUM AMBROSIOIDES; CHILD; CLINICAL TRIAL; COLD CLIMATE; COMPLICATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; COST EFFECTIVENESS ANALYSIS; COUGHING; DIARRHEA; DISEASE TRANSMISSION; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; ENDEMIC DISEASE; EOSINOPHILIA; FICUS; FOOD CONTAMINATION; HAND; HUMAN; HYPERSENSITIVITY; IMMUNOTOXICITY; INFANT; INTESTINE; INTESTINE INFECTION; INTESTINE OBSTRUCTION; LIVER DYSFUNCTION; LUNG INFECTION; MORBIDITY; MORTALITY; MOUSE; MULTICENTER STUDY; NAUSEA; NEMATODE; NEMATODIASIS; NEUROTOXICITY; NEUTROPENIA; NONHUMAN; PARASITE; PLANT; PNEUMONIA; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SINGLE BLIND PROCEDURE; SWINE; THROMBOCYTOPENIA; TROPICS; VOMITING;

ANIMALS; ANTIPARASITIC AGENTS; ASCARIASIS; ASCARIS LUMBRICOIDES; ASCARIS SUUM; CHILD; DISEASE TRANSMISSION, VERTICAL; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; RANDOMIZED CONTROLLED TRIALS; SWINE; SWINE DISEASES; TREATMENT OUTCOME;

EID: 0035022509     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.2.2.223     Document Type: Review

References (178)

1. Morbidity and mortality due to ascariasis: Re-estimation and sensitivity analysis of global numbers at risk
2. Ascariasis
3. Ascariasis
4. Ascaris suum: A revision of its early migratory path and implications for human ascariasis
5. Parasitic diseases of the liver
6. Natural immunity to Ascaris lumbricoides associated with immunoglobulin E antibody to ABA-1 allergen and inflammation indicators in children
7. Ascaris lumbricoides: Reinfection in children bearing an established worm burden
8. Heterogeneity in the expression of surface-exposed epitopes among larvae of Ascaris lumbricoides
9. The specificity of the antibody response to internal antigens of Ascaris: Heterogeneity in infected humans and MHC (H-2) control of the repertoire in mice
10. Genetic analysis of susceptibility to infection with Ascaris lumbricoides
11. A possible genetic factor influencing protection from infection with Ascaris lumbricoides in Nigerian children
12. The prevalence of ascariasis
13. Intensity of reinfection with Ascaris lumbricoides and its implications for parasite control
14. Predisposition to reinfection by intestinal helminths after chemotherapy in south Thailand
15. Ascariasis and hookworm
16. The intestinal nematodes
17. Nutritional status and the IgE response against Ascaris lumbricoides in children from a tropical slum
18. Evaluation of IgG4 response in ascariasis by ELISA for serodiagnosis
19. Ascaris lumbricoides infection is associated with protection from cerebral malaria
20. Index of suspicion. Case 1: Toxocara canis and Ascaris infection with lead poisoning
21. Familial analysis of eosinophilia caused by helminthic parasites
22. Peripheral and nasal eosinophilia and serum total immunoglobulin E levels in children with ascariasis
23. Morbidity and mortality in ascariasis
24. Linear growth retardation in Zanzibari school children
25. Relationship between soil-transmitted helminthiasis and growth in urban slum schoolchildren in Ujung Pandang, Indonesia
26. School-based deworming program yields small improvement in growth of Zanzibari school children after one year
27. The effects of deworming on indicators of school performance in Guatemala
28. Effect of removing Ascaris on the growth of Guatemalan school children
29. Physical fitness, growth and appetite of Kenyan schoolboys with hookworm, Trichuris trichiura and Ascaris lumbricoides infections are improved four months after a single dose of albendazole
30. Role of ascariasis in surgical abdominal emergencies in the Rangoon Children's Hospital, Burma
31. Potential for diagnosis of intestinal nematode infections through antibody detection in saliva
32. Degree of aggregation of Ascaris lumbricoides according to age groups after a massive anthelminthic intervention
33. Parasitic pneumonia
34. Intestinal nematodes (roundworms)
35. Intestinal obstruction caused by Ascaris lumbricoides
36. Intestinal nematodes (roundworms)
37. Liver abscess caused by Ascaris lumbricoides: Memorandum about hepatic changes in adopted children from developing countries
38. Liver abscess in Childhood: Report of 8 cases
39. Liver abscesses due to Ascaris lumbricoides
40. Round worm pancreatitis: Endoscopic worm removal without papillotomy
41. Gastrografin treatment of intestinal obstruction due to Ascaris lumbricoides
42. Small bowel volvulus complicating intestinal ascariasis in children
43. Ascaris lumbricoides and intestinal perforation
44. Ascariasis and acute otitis media
45. Intraocular ascaris larva
46. Parasitic uveitis in children
47. Intraocular Ascaris larva
48. Ascaris lumbricoides: An unusual cause of shunt infection
49. Churg-Strauss syndrome vasculitis and ascaris infection
50. Pulmonary infiltration, asthma and eosinophilia due to Ascaris suum infestation in man
51. Pulmonary ascariasis in tropical communities
52. Eosinophilia in travellers
53. Eosinophilic lung disease
54. Chronic course of eosinophilic pneumonia in infection with Ascaris lumbricoides
55. Management of intestinal obstruction caused by ascariasis
56. Intestinal ascariasis as a cause of bowel obstruction in two patients: Sonographic diagnosis
57. Ascaris lumbricoides infestation as a cause of intestinal obstruction in children: Experience with 87 cases
58. Morbidity and mortality due to Ascaris-induced intestinal obstruction
59. Intestinal nematodes that migrate through the lungs (ascariasis)
60. Soil-transmitted helminths (geohelminths)
61. Intestinal complications of round worms in children
62. Surgical complications of ascariasis
63. Gastric ascariasis
64. Gastric ascariasis associated with upper gastrointestinal hemorrhage
65. Gastric ascariasis: A rare cause of upper gastrointestinal bleeding
66. Endoscopy-assisted emergency treatment of gastroduodenal and pancreatobiliary ascariasis
67. Ascariasis, an infection to watch for in immigrants
68. Biliary ascariasis: Endoscopic extraction of a living worm from the bile duct
69. Biliary ascariasis
70. Biliary ascariasis
71. Hepatobiliary and pancreatic ascariasis
72. Pancreatic-biliary ascariasis: Experience of 300 cases
73. Management of biliary ascariasis in children
74. Biliary and pancreatic ascariasis: A long-term follow-up
75. Radiological findings of intraparenchymal liver Ascaris (hepatobiliary ascariasis)
76. Biliary ascariasis
77. Abdominal complications of Ascaris lumbricoides infestation in childhood
78. Endoscopic retrograde cholangiopancreatography and endoscopic papillotomy in recurrent pyogenic cholangitis
79. Gallblader ascariasis: Presentation and management
80. Ascariasis of the gallbladder: Radiological evaluation and follow-up
81. Laparoscopic cholecystectomy for gallbladder ascariasis
82. Ascariasis of the kidney
83. The passage of numerous Ascaris lumbricoides from the male urethra: Report of a case
84. Unusual cases of parasitic infections in Papua New Guinea
85. Ascariasis of the gallbladder: Report of 2 cases and review of the literature
86. Intraperitoneal ascariasis
87. Granulomatous peritonitis by ascaris
88. Ascaris lumbricoides appendicitis in the tropics
89. Preoperative sonographic diagnosis of acute appendicitis caused by Ascaris lumbricoides
90. Biliary ascariasis: Sonographic findings
91. Intestinal parasitic infections: A soluble public health problem
92. A controlled evaluation of two school-based anthhelminthic chemotherapy regimens on intensity of intestinal helminth infections
93. A study of the cost effectiveness of selective health interventions for the control of intestinal parasites in rural Bangladesh
94. Control of Ascaris infection by chemotherapy: Which is the most cost-effective option?
95. Surgical complications of intestinal ascariasis
96. Biliary ascariasis: Surgical aspects
97. Hypertonic saline enema in gastrointestinal ascariasis
98. Surgical ascariasis in children in Kashmir
99. Laparoscopic treatment for biliary ascariasis
100. Antiparasitic drugs
101. Unusual ingestion of a nasogastric tube by Ascaris lumbricoides
102. An unusual cause of nasogastric tube obstruction
103. Nasogastric obstruction by Ascaris lumbricoides
104. Drug treatment in intestinal helminthiasis
105. Viability of Ascaris lumbricoides eggs eliminated after anti-helminthic therapy
106. Acalculous cholecystitis: Ascariasis as an unusual cause
107. Experience with the use of nemocide (pyrantel pamoate) in nematodiases
108. Phenotypic analysis of hypodense eosinophils derived from ascites of a patient with ascariasis
109. Myasthenia gravis aggravated by pyrantel pamoate
110. Selective treatment and targeted chemotherapy: Effect on prevalence and intensity of infection for two intestinal helminths in Nepalese children
111. Mebendazole 500 mg for single-dose treatment of nematode infestation
112. Mebendazole and Ascaris migration
113. Single dose mebendazole therapy for soil-transmitted nematodes
114. Biliary ascariasis in fifteen patients
115. Electrophysiological effects of piperazine and diethylcarbamazine on Ascaris suum somatic muscle
116. Evolution of operational research studies and development of a national control strategy against intestinal helminths in Pemba Island, 1988-1992
117. Measurement of Ascaris lumbricoides infection intensity and the dynamics of expulsion following treatment with mebendazole
118. Granulomatous hepatitis due to mebendazole
119. Effect of intestinal helminthiasis on school attendance by early primary schoolchildren
120. Albendazole, a broad-spectrum anthelminthic, in the treatment of intestinal nematode and cestode infection: A multicenter study in 480 patients
121. Albendazole in the treatment of intestinal helminthiasis in children
122. Ovicidal effects of albendazole in human ascariasis, ancylostomiasis and trichuriasis
123. Endoscopic retrograde cholangiopancreatography diagnosis and extraction of massive biliary ascariasis presented with acute pancreatitis: A case report
124. Albendazole in the treatment of geohelminth infections in children
125. Quantitative assessment of Ascaris lumbricoides infection in school children from a slum in Visakhapatnam, south India. Southeast Asian
126. Albendazole in the treatment of intestinal helminthiasis in children
127. The efficacy of treatment with albendazole
128. Intraductal administration of albendazole for biliary ascariasis
129. Albendazole: Placebo-controlled study in 870 patients with intestinal helminthiasis
130. A cost-effectiveness analysis of anthelminthic intervention for community control of soil-transmitted helminth infection: Levamisole and Ascaris lumbricoides
131. Targeted anthelminthic treatment of school children: Effect of frequency of application on the intensity of Ascaris lumbricoides infection in children from rural Nigerian villages
132. A school- based approach to the control of urinary schistosomiasis and intestinal helminth infections in children in Matuga, Kenia: Impact of a two-year chemotherapy programme on prevalence and intensity of infections
133. Relationship between levamisole and encephalitis syndrome
134. Viability of Ascaris lumbricoides ova after human treatment with specific drugs. I. Levamisole and pyrantel pamoate
135. A randomized controlled trial comparing mebendazole and albendazole against Ascaris, Trichuris and hookworm infections
136. Ivermectin in human medicine
137. Effect of ivermectin (mectizan) on intestinal nematodes
138. A field study of the effect of ivermectin on intestinal helminths in man
139. The effects of ivermectin in the chemotherapy of gastrointestinal helminthiasis in humans
140. Clinical observation on efficacy of ivermectin in the treatment of intestinal nematode infections
141. Clinical observation on the treatment of hookworm, Ascaris and Tricuris infection with oxibendazole
142. Radiographic plain film and CT findings in lipoid pneumonia in infants following aspiration of mineral oil used in the treatment of partial small bowel obstruction by Ascaris lumbricoides
143. Single dose therapy of ascariasis - A randomized comparison of mebendazole and pyrantel
144. A study of the effectiveness of mebendazole and pyrantel pamoate as a combination anthelminthic in Papua New Guinean children
145. Efficacy of a single dose of mebendazole on prevalence and intensity of soil transmitted nematodes in Zanzibar
146. Rate of reinfection with intestinal nematodes after treatment of children with mebendazole and albendazole in a highly endemic area
147. Reducing intestinal nematode infection: Efficacy of albendazole and mebendazole
148. Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren
149. Clinical observation on combined use of herbal medicine and acupuncture for treatment of 50 cases of biliary ascariasis complicated by infection
150. Preclinical and clinical studies with latex from Ficus glabrata HBK, a traditional intestinal anthelminthic in the Amazonian area
151. Studies on the traditional herbal anthelminthic Chenopodium ambrosidiosis L. Ethnopharmacological evaluation and clinical field trials
152. Acute pancreatitis in pregnancy with ascaris infection
153. Acute pancreatitis caused by biliary Ascaris in pregnancy
154. Neonatal ascariasis
155. Nematode infections: Is it wise to withhold medical treatment during pregnancy? I. Biliary complications
156. Obstruction intestinal por ascaris y embarazo. Presentacion de un caso
157. The effect on fetal growth of protozoan and helminthic infection during pregnancy
158. Fetal response to maternal ascaris as evidenced by anti-Ascaris lumbricoides IgM antibodies in the cord blood
159. Ascaris lumbricoides in neonate: Evidence of congenital transmission of intestinal nematodes
160. Ascariasis
161. The ABA-1 allergen of Ascaris lumbricoides: Sequence polymorphism, stage and tissue-specific expression, lipid binding function and protein biophysical properties
162. Distribution of Ascaris suum in experimentally and naturally infected pigs and comparison with Ascaris lumbricoides infections in humans
163. N-terminal amino acid sequence identity between a major allergen of Ascaris lumbricoides and Ascaris suum and MHC- restricted IgE responses to it
164. Antigenic relationships between the surface-exposed, secreted and somatic materials of the nematode parasites Ascaris lumbricoides, Ascaris suum and Toxocara canis
165. The secreted and somatic antigens of the third stage larva of Anisakis simplex and antigenic relationship with Ascaris suum, Ascaris lumbricoides and Toxocara canis
166. Biliary ascariasis
167. Human infection with porcine Ascaris
168. An outbreak of visceral larva migrans due to Ascaris suum in Kyushu, Japan
169. Larva migrans syndrome: Toxocara, ascaris or both?
170. Encephalopathy caused by visceral larva migrans due to Ascaris suum
171. Hepatic imaging studies on patients with visceral larva migrans due to probable Ascaris suum infection
172. Can Ascaris suum cause visceral larva migrans?
173. Immunorestorative effect of glucan immunomodulator on guinea pigs with experimental ascariosis
174. The effect of copper on immune responses in guinea pigs with experimental ascariasis
175. Ascaris suum-vaccination of mice with liposome encapsulated antigen
176. Ascaris infections in humans from North America: Molecular evidence for cross-infection